FIELD: medicine. SUBSTANCE: method involves injecting 1% thiotriazoline solution at a dose of 0.5 ml once a day in parabulbar administration mode during 10- 14 days. EFFECT: enhanced effectiveness of treatment; accelerated treatment course. 2 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING OCCLUDING INJURIES OF CORNEAL AND OPTIC-NERVE VESSELS | 1995 |
|
RU2122384C1 |
| METHOD FOR CARRYING OUT CONSERVATIVE TREATMENT OF BURNED EYES | 1995 |
|
RU2120263C1 |
| METHOD FOR TREATING TUBERCULOUS UVEITES | 2006 |
|
RU2318534C2 |
| METHOD OF TREATING DISEASES OF OPTIC NERVE AND RETINA | 2008 |
|
RU2373904C1 |
| METHOD FOR TREATMENT MACULODISTROPHY | 0 |
|
SU1650129A1 |
| TETRAPEPTIDE STIMULATING EYE RETINA FUNCTION, PHARMACOLOGICAL AGENT BASED ON THEREOF AND METHOD OF ITS USING | 2000 |
|
RU2161982C1 |
| METHOD FOR TREATMENT OF TUBERCULOSIS UVEITIS | 2004 |
|
RU2290191C2 |
| METHOD OF TREATING HERPES VIRUS INVOLVEMENT OF INNER STRUCTURES OF EYE | 2012 |
|
RU2539161C2 |
| METHOD OF TREATING DEGENERATIVE AND DYSTROPHIC RETINAL DISEASES | 2012 |
|
RU2495669C1 |
| METHOD FOR PREDICTING PATHOLOGICAL RETINAL STATE AND DECREASED VISUAL FUNCTIONS IN CASE OF PROGRESSING MYOPIA | 2003 |
|
RU2229261C1 |
